Recently, Senbanjo et al. demonstrated that RUNX2 complexes with the CD44 intracellular domain, thus inducing the expression of metastasis-related genes and increasing migration ability, as well as the formation of tumorspheres in prostatic cancer cells [41]. Here, RUNX2 is linked to prostate carcinoma.